Dominick Conde analyzes the Supreme Court’s January 20th, 2015 decision in Teva Pharmaceuticals v. Sandoz, which overturned the Federal Circuit’s de novo standard of review for district court claim constructions, and its implications on future patent litigations.
March 2015 | Intellectual Property Today
Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc.: Where Does Claim Construction Go From Here?
1 min
Related Services
Related Insights
Fighting Counterfeits at the U.S. Border: The Counterfeit Goods Seizure Act of 2019 Would Expand Customs and Border Patrol Enforcement to Design Patents
Fighting Counterfeits at the U.S. Border: The Counterfeit Goods Seizure Act of 2019 Would Expand Customs and Border Patrol Enforcement to Design Patents
August 13, 2020
6min
Maximizing the Value of Brands and Creative Works in Challenging Times
Maximizing the Value of Brands and Creative Works in Challenging Times
July 28, 2020
5min
Legal Implications of Syncing Copyrighted Music with Other Content
Legal Implications of Syncing Copyrighted Music with Other Content
July 14, 2020
6min
Recent News
Grant Schneider to Present Closing Keynote Speech at the Forcepoint Virtual Cybersecurity Summit: Government on the Edge on September 24
Grant Schneider to Present Closing Keynote Speech at the Forcepoint Virtual Cybersecurity Summit: Government on the Edge on September 24
September 24, 2020
1min
Washington Business Journal Recognizes Venable Among the Largest Private Companies in Greater DC
Washington Business Journal Recognizes Venable Among the Largest Private Companies in Greater DC
September 18, 2020
1min
World Trademark Review Quotes Andrew Price on Obtaining Configuration Trademarks
World Trademark Review Quotes Andrew Price on Obtaining Configuration Trademarks
September 18, 2020
2min